logo
Twitter
Discord
Email
logo
LifeStance Health Group, Inc.

LifeStance Health Group, Inc.

NASDAQ•LFST
CEO: Mr. Kenneth Alan Burdick
Sector: Healthcare
Industry: Medical - Care Facilities
Listing Date: 2021-06-10
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.
Contact Information
4800 North Scottsdale Road, Suite 2300, Scottsdale, AZ, 85251, United States
602-767-2100
lifestance.com
Market Cap
$2.69B
P/E (TTM)
-293.7
25.9
Dividend Yield
--
52W High
$8.30
52W Low
$3.74
52W Range
70%
Rank70Top 94.8%
1.5
F-Score
Modified Piotroski Analysis
Based on 6-year fundamentals
Weak • 1.5 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2019-2024

Financial Dashboard

Q3 2025 Data

Revenue

$363.81M+16.34%
4-Quarter Trend

EPS

$0.00-117.83%
4-Quarter Trend

FCF

$17.00M-3.82%
4-Quarter Trend

2025 Q3 Earnings Highlights

Key Highlights

Nine Month Revenue Growth Total revenue reached $1.042B USD for nine months, up 13% from $925.5M USD last year.
Operating Income Turnaround Three month operating income $7.4M USD, massive improvement from $47K USD prior period comparison.
Net Loss Significantly Narrows Nine month net loss reduced to $2.0M USD versus $50.3M USD loss reported in 2024.
Operating Cash Flow Doubles Cash provided by operations $88.6M USD for nine months, nearly doubling prior year's $44.9M USD.

Risk Factors

Internal Control Material Weakness Material weaknesses persist in internal control over financial reporting, impacting IT and accounting procedures.
Payor Rate Reduction Risk Business harmed if third-party payor reimbursement rates are reduced or care delivery is restrained by payors.
Reliance on Practice Relationships Business harmed if relationships with supported practices, which are not owned, are disrupted or face legal challenges.

Outlook

Expanding Clinician Base Opportunity exists to grow employed clinician base from 7,996 as strategic recruiting efforts continue expansion plans.
Organic Center Growth Focus New center strategy central to organic growth, building capacity and increasing density in existing and new markets.
Drive Center Margin Growth Seek consistent returns by growing revenue and leveraging fixed costs; realize synergies from recent acquisitions.

Peer Comparison

Revenue (TTM)

Ardent Health Partners, Inc.ARDT
$6.33B
+10.9%
Select Medical Holdings CorporationSEM
$5.37B
-23.0%
Acadia Healthcare Company, Inc.ACHC
$3.27B
+4.6%

Gross Margin (Latest Quarter)

Acadia Healthcare Company, Inc.ACHC
96.7%
+72.8pp
LeMaitre Vascular, Inc.LMAT
75.3%
+7.5pp
Artivion, Inc.AORT
65.6%
+1.9pp

Key Metrics

Symbol
Market Cap
P/E (TTM)
ROE (TTM)
Debt to Assets
LFST$2.69B-293.7-0.6%22.0%
BKD$2.44B-7.8-267.9%19.2%
NHC$2.16B20.510.5%11.0%

Long-Term Trends

Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
3.8%
Moderate Growth
4Q Net Income CAGR
N/M
Profitability Shift
Cash Flow Stability
75%
Volatile Cash Flow

Research & Insights

Next earnings:Feb 26, 2026
|
EPS:-
|
Revenue:-
Reports
All Years

  • Form 10-Q - Q3 2025

    Period End: Sep 30, 2025|Filed: Nov 6, 2025|
    Revenue: $363.81M+16.3%
    |
    EPS: $0.00-117.8%
    Beat

  • Form 10-Q - Q2 2025

    Period End: Jun 30, 2025|Filed: Aug 7, 2025|
    Revenue: $345.31M+10.6%
    |
    EPS: $-0.01-84.0%
    Beat

  • Form 10-Q - Q1 2025

    Period End: Mar 31, 2025|Filed: May 7, 2025|
    Revenue: $332.97M+10.8%
    |
    EPS: $0.00-103.2%
    Beat

  • Form 10-K - FY 2024

    Period End: Dec 31, 2024|Filed: Feb 27, 2025|
    Revenue: $1.25B+18.5%
    |
    EPS: $-0.15+70.6%
    Miss

  • Form 10-Q - Q3 2024

    Period End: Sep 30, 2024|Filed: Nov 7, 2024|
    Revenue: $312.72M+19.0%
    |
    EPS: $-0.02-90.8%
    Beat

  • Form 10-Q - Q2 2024

    Period End: Jun 30, 2024|Filed: Aug 8, 2024|
    Revenue: $312.33M+20.3%
    |
    EPS: $-0.06-52.8%
    Beat

  • Form 10-Q - Q1 2024

    Period End: Mar 31, 2024|Filed: May 9, 2024|
    Revenue: $300.44M+18.9%
    |
    EPS: $-0.06-40.9%
    Beat

  • Form 10-K - FY 2023

    Period End: Dec 31, 2023|Filed: Feb 28, 2024|
    Revenue: $1.06B+22.8%
    |
    EPS: $-0.51+16.4%
    Miss